首页> 美国卫生研究院文献>BMJ Open >Trial protocol to compare the efficacy of a smartphone-based blood glucose management system with standard clinic care in the gestational diabetic population
【2h】

Trial protocol to compare the efficacy of a smartphone-based blood glucose management system with standard clinic care in the gestational diabetic population

机译:一项试验协议将基于智能手机的血糖管理系统与标准临床护理在妊娠糖尿病人群中的功效进行比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionThe prevalence of gestational diabetes mellitus (GDM) is rising in the UK. Good glycaemic control improves maternal and neonatal outcomes. Frequent clinical review of patients with GDM by healthcare professionals is required owing to the rapidly changing physiology of pregnancy and its unpredictable course. Novel technologies that allow home blood glucose (BG) monitoring with results transmitted in real time to a healthcare professional have the potential to deliver good-quality healthcare to women more conveniently and at a lower cost to the patient and the healthcare provider compared to the conventional face-to-face or telephone-based consultation. We have developed an integrated GDm-health management system and aim to test the impact of using this system on maternal glycaemic control, costs, patient satisfaction and maternal and neonatal outcomes compared to standard clinic care in a single large publicly funded (National Health Service (NHS)) maternity unit.
机译:简介在英国,妊娠糖尿病(GDM)的患病率正在上升。良好的血糖控制可改善孕妇和新生儿的结局。由于妊娠生理的快速变化及其不可预测的过程,医疗保健专业人员需要对GDM患者进行频繁的临床检查。与传统技术相比,允许对家庭血糖(BG)进行实时监测并将结果实时传输给医疗保健专业人员的新技术有可能更方便地为妇女提供高质量的医疗保健,并且为患者和医疗保健提供者提供更低的成本面对面或电话咨询。我们已经开发了一个整合的GDm-健康管理系统,旨在测试与单一大型公共资助的标准临床护理相比,使用该系统对孕妇血糖控制,成本,患者满意度以及母婴新生儿结局的影响(国家卫生服务( NHS))生育单位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号